LeMaitre Vascular, Inc. (LMAT)

Last Closing Price: 81.13 (2025-06-13)

Company Description

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $219.86M
Net Income (Most Recent Fiscal Year) $44.04M
PE Ratio (Current Year Earnings Estimate) 37.46
PE Ratio (Trailing 12 Months) 40.97
PEG Ratio (Long Term Growth Estimate) 2.14
Price to Sales Ratio (Trailing 12 Months) 8.10
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 5.27
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 33.96
Pre-Tax Margin (Trailing 12 Months) 25.78%
Net Margin (Trailing 12 Months) 19.96%
Return on Equity (Trailing 12 Months) 13.53%
Return on Assets (Trailing 12 Months) 9.78%
Current Ratio (Most Recent Fiscal Quarter) 16.49
Quick Ratio (Most Recent Fiscal Quarter) 13.83
Debt to Common Equity (Most Recent Fiscal Quarter) 0.48
Inventory Turnover (Trailing 12 Months) 1.09
Book Value per Share (Most Recent Fiscal Quarter) $15.00
Earnings per Share (Most Recent Fiscal Quarter) $0.48
Earnings per Share (Most Recent Fiscal Year) $1.93
Diluted Earnings per Share (Trailing 12 Months) $1.98
Stock
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 22.59M
Free Float 20.45M
Market Capitalization $1.83B
Average Volume (Last 20 Days) 0.16M
Beta (Past 60 Months) 0.83
Percentage Held By Insiders (Latest Annual Proxy Report) 9.50%
Percentage Held By Institutions (Latest 13F Reports) 84.64%
Annual Dividend (Based on Last Quarter) $0.80
Dividend Yield (Based on Last Quarter) 0.99%